We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

130 hedge funds and large institutions have $40.7M invested in Sanofi Contingent Value Rights in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 136 → 130 (-6)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

88% less capital invested

Capital invested by funds: $338M → $40.7M (-$297M)

Holders
130
Holders Change
-6
Holders Change %
-4.41%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
26
Increased
24
Reduced
32
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$11.4M
2
CPM
Chesapeake Partners Management
Maryland
+$5.44M
3
MCM
Mason Capital Management
New York
+$4.18M
4
PWAM
Park West Asset Management
California
+$3.63M
5
SI
Standard Investments
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
DI
Dalton Investments
Nevada
-$34M
2
SC
Sculptor Capital
New York
-$24.1M
3
ACM
Abrams Capital Management
Massachusetts
-$23.6M
4
AC
Aristeia Capital
Connecticut
-$13.2M
5
AAA
Alpine Associates Advisors
New Jersey
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
76
University of Chicago
Illinois
$4K – – –
LPL Financial
77
LPL Financial
California
$4K +$28 +23 +0.2%
Invesco
78
Invesco
Georgia
$3K – – –
BAM
79
Brave Asset Management
New Jersey
$3K +$12.1K +10,000 New
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$2.21K -$96.7K -80,000 -92%
Deutsche Bank
81
Deutsche Bank
Germany
$2K -$846 -700 -8%
CTC
82
Central Trust Company
Missouri
$2K -$45 -37 -0.5%
US Bancorp
83
US Bancorp
Minnesota
$2K -$39 -32 -0.4%
Creative Planning
84
Creative Planning
Kansas
$1K -$9.67K -8,005 -83%
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
$1K -$726 -601 -24%
LTFS
86
Ladenburg Thalmann Financial Services
Florida
$1K -$483 -400 -17%
BPBT
87
Boston Private Bank & Trust
Massachusetts
$1K -$363 -300 -7%
M&T Bank
88
M&T Bank
New York
$1K – – –
MWP
89
MYCIO Wealth Partners
Pennsylvania
$1K – – –
NEAM
90
New England Asset Management
Connecticut
$1K – – –
RNS
91
Robert N. Shapiro
$1K – – –
TWA
92
TCI Wealth Advisors
Arizona
$1K – – –
WT
93
Whittier Trust
California
$1K – – –
WTC
94
WhitTier Trust Company
Nevada
$1K – – –
California Public Employees Retirement System
95
California Public Employees Retirement System
California
$1K +$1.33K +1,100 New
HF
96
Hoxton Financial
West Virginia
$1K +$2.46K +2,039 New
V
97
Veritable
Delaware
$1K +$5.08K +4,203 New
SAM
98
Silverback Asset Management
North Carolina
$736 +$792K +655,271 +43%
AIG
99
American International Group
New York
$446 – – –
ECM
100
Estabrook Capital Management
New York
$5 – – –
2 3
4
5 6

GCVRZ Hedge Fund Activity: Q4 2013 in Review

130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2013, worth a combined $40.7M — down 88% from $338M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of GCVRZ and 26 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $11.4M. The largest seller was Dalton Investments, exiting entirely with an estimated $34M sold.

  • 130 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2013, down from 136 in Q3 2013.
  • Funds reported $40.7M of Sanofi Contingent Value Rights stock for Q4 2013, down 88% quarter-over-quarter.
  • 26 funds opened new Sanofi Contingent Value Rights positions in Q4 2013 and 31 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2013 was Fir Tree Capital Management, an estimated $11.4M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2013 was Dalton Investments, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2013.